PTGS2 and depressive symptom measurement: COX-2 inhibitors have been observed to have a positive effect on neuronal inflammation and the severity of the depression [162,163,164], whereas a single-nucleotide polymorphism of the COX-2 gene may represent a risk for recurrent depressive disorder [165].